
Heilongjiang ZBD Pharmaceutical Co., Ltd.
SSE:603567.SS
11.25 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Heilongjiang ZBD Pharmaceutical Co., Ltd. |
Symbool | 603567.SS |
Munteenheid | CNY |
Prijs | 11.25 |
Beurswaarde | 10,569,835,294 |
Dividendpercentage | 0.22% |
52-weken bereik | 9.81 - 13.63 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Hai Chen |
Website | https://www.zbdzy.com |
An error occurred while fetching data.
Over Heilongjiang ZBD Pharmaceutical Co., Ltd.
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)